Group 1: Financial Performance - The company achieved a revenue of 5.362 billion yuan in H1 2025, representing a year-on-year increase of 7.21%, with a net profit of 799 million yuan, up 13.80% year-on-year [1] - In Q2 2025, the company reported a revenue of 3 billion yuan, a year-on-year increase of 6.49%, and a net profit of 408 million yuan, up 2.4% year-on-year [1] - The company proposed a cash dividend of 3.15 billion yuan, with a payout ratio of 39.5% [1] Group 2: Profitability and Cost Management - The gross margin for H1 2025 was 73.4%, an increase of 3.6 percentage points year-on-year, while the net profit margin was 15.4%, up 0.9 percentage points year-on-year [1] - The sales expense ratio increased to 49.59%, primarily due to increased promotional activities and new product investments [1] - The management expense ratio decreased to 3.31%, and the R&D expense ratio was 1.77%, both showing slight year-on-year improvements [1] Group 3: Brand Performance and Market Strategy - The main brand, Proya, generated revenue of 3.979 billion yuan, a slight decline of 0.08% year-on-year, while new products enhanced category competitiveness [2] - Growth brands showed strong performance, with Caitang achieving revenue of 705 million yuan, up 21.11% year-on-year, and Off&Relax (OR) reaching 279 million yuan, a significant increase of 102.52% year-on-year [2] - New brands are gradually gaining traction, with revenue from Original Pot reaching 97 million yuan, up 80.18% year-on-year, and Yuefuti generating 166 million yuan, up 3.31% year-on-year [2] Group 4: Strategic Initiatives - The company plans to issue H shares and list on the Hong Kong Stock Exchange to accelerate internationalization and enhance overseas financing capabilities [3] - The "Double Ten" strategy is being implemented to reduce costs and improve efficiency, while the multi-brand matrix continues to break through in niche markets [3] - Long-term competitive advantages are expected to strengthen with the continuation of the new product cycle and growth from emerging brands [3]

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company's performance met expectations, with profit growth outpacing revenue growth. In H1 2025, total revenue reached 5.362 billion yuan (up 7.21% YoY), and net profit attributable to shareholders was 799 million yuan (up 13.80% YoY) [7] - The company is planning a Hong Kong stock listing to accelerate international development and enhance overseas financing capabilities [7] - The new management strategy has shown initial results, with over 10 new products launched in the first half of 2025, expanding into new categories such as whitening and medical beauty [7] Financial Summary - Total revenue projections for 2025 are estimated at 11.854 billion yuan, with a YoY growth rate of 10.0% [6] - The net profit attributable to shareholders is projected to be 1.756 billion yuan in 2025, reflecting a YoY growth rate of 13.1% [6] - The gross margin for H1 2025 was reported at 73.4%, an increase of 3.6 percentage points YoY, while the net profit margin was 15.4%, up 0.9 percentage points YoY [7]